TY - JOUR
T1 - Patent Strategies and Competition Law in the Pharmaceutical Sector
T2 - Implications for Access to Medicines
AU - Matthews, Duncan
AU - Gurgula, Olga
PY - 2016/5/16
Y1 - 2016/5/16
N2 - Potentially anti-competitive practices, such as reverse payment agreements and strategic patenting, risk allowing pharmaceutical companies to block the entry of generic and innovative medicines, stifling competition and harming consumers. Such practices create particular challenges for developing countries. Policy coherence between the IP system and competition law must be strengthened in order to promote innovation and access to health technologies.
AB - Potentially anti-competitive practices, such as reverse payment agreements and strategic patenting, risk allowing pharmaceutical companies to block the entry of generic and innovative medicines, stifling competition and harming consumers. Such practices create particular challenges for developing countries. Policy coherence between the IP system and competition law must be strengthened in order to promote innovation and access to health technologies.
UR - http://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?recordid=460
M3 - Article
SN - 0142-0461
VL - 38
SP - 661
EP - 667
JO - European Intellectual Property Review
JF - European Intellectual Property Review
IS - 11
ER -